These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Oxygen radicals and substance P in perinatal hypoxia-exaggerated, monocrotaline-induced pulmonary hypertension. Chen KH; Lai YL; Chen MJ Chin J Physiol; 2012 Apr; 55(2):82-90. PubMed ID: 22559732 [TBL] [Abstract][Full Text] [Related]
9. Glycyrrhizin, inhibitor of high mobility group box-1, attenuates monocrotaline-induced pulmonary hypertension and vascular remodeling in rats. Yang PS; Kim DH; Lee YJ; Lee SE; Kang WJ; Chang HJ; Shin JS Respir Res; 2014 Nov; 15():148. PubMed ID: 25420924 [TBL] [Abstract][Full Text] [Related]
10. Alterations in pharmacological action of the right ventricle of monocrotaline-induced pulmonary hypertensive rats. Daicho T; Yagi T; Takano S; Marunouchi T; Abe Y; Ohara M; Takeo S; Tanonaka K Biol Pharm Bull; 2009 Aug; 32(8):1378-84. PubMed ID: 19652377 [TBL] [Abstract][Full Text] [Related]
11. Specific inhibition of p38 mitogen-activated protein kinase with FR167653 attenuates vascular proliferation in monocrotaline-induced pulmonary hypertension in rats. Lu J; Shimpo H; Shimamoto A; Chong AJ; Hampton CR; Spring DJ; Yada M; Takao M; Onoda K; Yada I; Pohlman TH; Verrier ED J Thorac Cardiovasc Surg; 2004 Dec; 128(6):850-9. PubMed ID: 15573069 [TBL] [Abstract][Full Text] [Related]
12. Roles of endothelin ETA and ETB receptors in the pathogenesis of monocrotaline-induced pulmonary hypertension. Nishida M; Eshiro K; Okada Y; Takaoka M; Matsumura Y J Cardiovasc Pharmacol; 2004 Aug; 44(2):187-91. PubMed ID: 15243299 [TBL] [Abstract][Full Text] [Related]
14. PRX-08066, a novel 5-hydroxytryptamine receptor 2B antagonist, reduces monocrotaline-induced pulmonary arterial hypertension and right ventricular hypertrophy in rats. Porvasnik SL; Germain S; Embury J; Gannon KS; Jacques V; Murray J; Byrne BJ; Shacham S; Al-Mousily F J Pharmacol Exp Ther; 2010 Aug; 334(2):364-72. PubMed ID: 20430844 [TBL] [Abstract][Full Text] [Related]
15. Contribution of endogenous endothelin-1 to the progression of cardiopulmonary alterations in rats with monocrotaline-induced pulmonary hypertension. Miyauchi T; Yorikane R; Sakai S; Sakurai T; Okada M; Nishikibe M; Yano M; Yamaguchi I; Sugishita Y; Goto K Circ Res; 1993 Nov; 73(5):887-97. PubMed ID: 8403258 [TBL] [Abstract][Full Text] [Related]
16. Urantide alleviates monocrotaline induced pulmonary arterial hypertension in Wistar rats. Mei Y; Jin H; Tian W; Wang H; Wang H; Zhao Y; Zhang Z; Meng F Pulm Pharmacol Ther; 2011 Aug; 24(4):386-93. PubMed ID: 21396478 [TBL] [Abstract][Full Text] [Related]
17. Aspirin attenuates monocrotaline-induced pulmonary arterial hypertension in rats by suppressing the ERK/MAPK pathway. Gao H; Cheng Y; Zong L; Huang L; Qiao C; Li W; Gong B; Hu J; Liu H; Wang X; Zhao C Clin Exp Hypertens; 2017; 39(1):34-41. PubMed ID: 28055284 [TBL] [Abstract][Full Text] [Related]